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Caffeine inhibits the checkpoint kinase ATM
Alessandra Blasina*, Brendan D. Price†, Gaetan A. Turenne†
and Clare H. McGowan*
The basis of many anti-cancer therapies is the use of
genotoxic agents that damage DNA and thus kill
dividing cells. Agents that cause cells to override the
DNA-damage checkpoint are predicted to sensitize cells
to killing by genotoxic agents. They have therefore
been sought as adjuncts in radiation therapy and
chemotherapy. One such compound, caffeine,
uncouples cell-cycle progression from the replication
and repair of DNA [1,2]. Caffeine therefore serves as a
model compound in establishing the principle that
agents that override DNA-damage checkpoints can be
used to sensitize cells to the killing effects of genotoxic
drugs [3]. But despite more than 20 years of use, the
molecular mechanisms by which caffeine affects the
cell cycle and checkpoint responses have not been
identified. We investigated the effects of caffeine on
the G2/M DNA-damage checkpoint in human cells. We
report that the radiation-induced activation of the
kinase Cds1 [4] (also known as Chk2 [5]) is inhibited by
caffeine in vivo and that ATM kinase activity is directly
inhibited by caffeine in vitro. Inhibition of ATM provides
a molecular explanation of the attenuation of DNA-
damage checkpoint responses and for the increased
radiosensitivity of caffeine-treated cells [6–8].
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Results and discussion
In human cells, the damage-induced delay in G2 is largely
due to the inhibitory phosphorylation of Cdc2 [9,10]. Cdc2
is phosphorylated on two sites and dephosphorylation of
these sites is catalyzed by the dual-specificity phosphatase
Cdc25 [11]. Recent evidence suggests that the G2 delay
involves inactivation and translocation of Cdc25 [4,12,13].
Two human kinases have been reported to phosphorylate
and inactivate Cdc25 in vitro [4,5,14], and at least one of
them, Cds1, is activated in a checkpoint-dependent manner
in response to γ-irradiation [4,5]. We investigated the possi-
bility that caffeine might override the DNA-damage-
induced checkpoint by inhibiting the activation of Cds1.
Consistent with previous reports [4,5], Cds1 was activated in
a dose- and time-dependent manner following γ-irradiation
(Figures 1a,b). Addition of 2 mM caffeine to HeLa cells
before irradiation greatly reduced the radiation-induced
activation of Cds1 (Figure 1c). Thus caffeine either inhibits
the activation of Cds1, or it directly inhibits Cds1 activity.
Addition of caffeine after irradiation had only a modest
effect on the activity of Cds1 (Figure 1c), suggesting that
caffeine prevented the full activation of Cds1 but that it did
not inhibit Cds1 once it was active. We also tested the possi-
bility that caffeine inhibits Cds1 activity directly. 
In vitro kinase assays of Cds1 immunoprecipitated from irra-
diated HeLa cells (Figure 1d), or of recombinant histidine-
tagged Cds1 (6His–Cds1) from Sf9 cells (Figure 1e),
showed that caffeine does not directly inhibit Cds1. Instead,
the data suggest that caffeine prevents the activation of
Cds1; therefore, an upstream activator of Cds1 might be a
target of inhibition by caffeine. One such candidate protein
is ATM, which is required for the radiation-induced activa-
tion of Cds1 in vivo [5]. Because ATM is inhibited by the
radiosensitizer wortmannin [15], we argued that the radia-
tion-induced activation of Cds1 should also be sensitive to
wortmannin. To test this idea, HeLa cells were incubated in
the presence of wortmannin for 15 minutes before irradia-
tion. Cells were harvested 1 hour after irradiation and Cds1
activity was monitored. As predicted for an ATM-depen-
dent process, the radiation-induced activation of Cds1 was
almost completely abolished in the presence of wortmannin.
In contrast, addition of wortmannin after irradiation had
little effect on Cds1 activity (Figure 1f). These data suggest
that, like wortmannin, caffeine inhibits the activation of
Cds1 by inhibiting ATM activity. The possibility that caf-
feine inhibits ATM directly was therefore tested. 
Conditions for the in vitro assay of ATM kinase activity,
with PHAS-I as a substrate, have been described recently
[16]. Phosphorylation of PHAS-I by ATM immunoprecipi-
tated from ATM+/+ cells was inhibited by wortmannin (see
Supplementary material), was increased following irradia-
tion (Figure 2a) and was dependent on the presence of
Mn2+ (data not shown) [16,17]. Furthermore, addition of
caffeine to ATM kinase assays inhibited phosphorylation of
PHAS I by more than 80% in five independent experi-
ments (Figure 2a). To ensure that ATM, and not an associ-
ated kinase, was being inhibited, epitope-tagged versions of
wild-type and a kinase-inactive form of ATM were trans-
fected into T293 cells and assayed in vitro. Phosphorylation
of PHAS-I was readily detectable in immunoprecipitates of
wild-type ATM, but not in immunoprecipitates of the
kinase-inactive construct (Figure 2b). The kinase activity of
recombinant ATM was inhibited by caffeine and wortman-
nin at concentrations that inhibit endogenous ATM. These
data strongly suggest that ATM kinase is directly inhibited
by caffeine, but the possibility that these assays measure
inhibition of an essential co-factor cannot be excluded.
It is possible that caffeine inhibits the activity of ATM
indirectly by binding to PHAS-I and altering its ability to
act as a substrate. Therefore, the effects of caffeine on
ATM activity using a second substrate were tested.
Because ATM is required for the radiation-induced modi-
fication and activation of Cds1 in vivo [5,18], the possibil-
ity that ATM directly phosphorylates Cds1 and that this
phosphorylation is sensitive to caffeine was investigated.
ATM immunoprecipitates were found to phosphorylate
a histidine-tagged kinase-inactive version of Cds1
(6His–Cds1D/A; Figure 2c). As seen with PHAS-I, phos-
phorylation of 6His–Cds1D/A was abolished by the addi-
tion of wortmannin (Figure 2a). Addition of caffeine
greatly reduced the ability of ATM to phosphorylate Cds1
in vitro. The inhibition of ATM kinase activity with two
unrelated substrates shows that caffeine is a substrate-
independent inhibitor of ATM kinase. The observation
that Cds1 is a substrate for ATM in vitro is consistent with
current models, which suggest that ATM directly phos-
phorylates Cds1 in vivo. Proof that Cds1 is a direct in vivo
substrate of ATM will require further studies.
To further study the effects of caffeine and wortmannin
on the activation of Cds1 in vivo, the effects of these drugs
were examined in ATM+/+ and ATM–/– cell lines. As was
seen in HeLa cells, γ-irradiation-induced activation of
Cds1 was greatly diminished in ATM+/+ lymphoblasts that
were cultured in the presence of caffeine or wortmannin
before irradiation (Figure 2d). As previously shown [5],
the damage-induced activation of Cds1 was also greatly
diminished in ATM–/– cells. The residual activation of
Cds1 detected in ATM–/– cells was diminished in the
presence of caffeine and wortmannin (Figure 2d). These
data suggest that activities other than ATM might con-
tribute minimally to the γ-irradiation-induced activation of
Cds1 and that these secondary activities are also sensitive
to inhibition by caffeine and wortmannin. The possibility
that ATM–/– cells contain residual ATM activity cannot
formally be excluded, however. The data are consistent
with the idea that ATM is required for the γ-irradiation-
induced activation of Cds1 and that inhibition of ATM by
caffeine accounts for the reduced activation of Cds1 in caf-
feine-treated cells. These results correlate with the
requirement for ATM and/or a caffeine-sensitive activity
in the downregulation of Cdc2–cyclin B activity following
irradiation (see Supplementary material).
The observation that caffeine inhibits ATM is consistent
with previous reports of the effects caffeine has on cell-
cycle progression and on the activity of cell-cycle effectors.
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Figure 1
Caffeine inhibits damage-induced activation of Cds1 in vivo. 
(a) Asynchronous HeLa cells were irradiated with the indicated doses
of γ-rays from a Cesium137 source and harvested 1 h later. (b) HeLa
cells were irradiated with 10 Gy and harvested at the indicated times.
(a,b) Cds1 was immunoprecipitated and assayed using [γ-32P]ATP as
described previously [4]. A PhosphorImager (Molecular Dynamics) was
used to quantify activity following SDS–PAGE. (c) Cds1 activity from
HeLa cells that had been irradiated in the absence (radiation) or
presence (caffeine + radiation) of 2 mM caffeine, which was added
before irradiation. Addition of caffeine before irradiation reduced Cds1
activity to 13% of the levels seen in irradiated cells. Addition of
caffeine 12 min after irradiation (radiation + caffeine) reduced activity
to 70% of that seen in irradiated cells. Similar results were obtained in
three independent experiments using HeLa cells and human
lymphoblasts. The control corresponds to cells that were not
irradiated. (d) Cds1 is not directly inhibited by caffeine. Cds1 was
immunoprecipitated from irradiated HeLa cells and assayed in the
presence and absence of 2 mM caffeine. In the presence of 2 mM
caffeine, the activity of Cds1 was 95 ± 5% of the control activity. 
(e) A synthetic peptide corresponding to residues 208–225 of human
mitosis-inducing phosphatase Cdc25c was used to assay the activity
of 6His–Cds1 purified from Sf9 cells in the presence or absence of
caffeine. Results are the average of duplicate points from two
independent experiments. (f) Addition of 5 µM wortmannin before
irradiation (wortmannin + radiation) reduced Cds1 activity to 5% of the
activity seen in irradiated cells. Addition of wortmannin after irradiation
(radiation + wortmannin) had little effect on activity (90% of irradiated
levels). The control corresponds to cells that were not irradiated.
Similar results were obtained in three independent experiments using
HeLa cells and human lymphoblasts. In (c,f) immunoblots confirmed
that equal amounts of Cds1 protein were recovered in
immunoprecipitates from control, irradiated and wortmannin- or
caffeine-treated cell extracts.
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For example, caffeine potentiates the lethality of the
DNA-damaging agent nitrogen mustard by inducing cells
to undergo mitosis before properly repairing damaged
DNA [1]. The loss of G2 delay in caffeine-treated cells
containing damaged DNA correlates with the inappropri-
ate dephosphorylation and activation of Cdc2–cyclin B
([8,19], see Supplementary material). Data from these
studies, coupled with the data presented here, suggest a
model in which caffeine prevents the activation of Cds1 by
ATM, which in turn prevents the inactivation of Cdc25
(Figure 3). Thus, dephosphorylation and activation of
Cdc2–cyclin B proceeds as it would in unirradiated cells.
As an inhibitor of ATM, caffeine would also be expected to
block the phosphorylation of the tumor suppressor p53,
and thus compromise the G1 arrest. A number of reports
show that caffeine indeed overrides the G1 checkpoint and
attenuates induction of p53 after γ-irradiation [6,20]. These
observations do not exclude the possibility that mam-
malian cells contain other caffeine-sensitive activities that
also contribute to checkpoint control. 
Caffeine has been widely used in studies of the DNA
replication checkpoint in mammalian cells and in
Xenopus extracts [2,21], although an ATM-like kinase has
not been identified in Xenopus. The observation that caf-
feine overrides a replication-induced delay in Xenopus
extracts [21], coupled with the report that caffeine blocks
the checkpoint-dependent phosphorylation of Chk1 in
Xenopus extracts [22], suggests that a caffeine-sensitive
ATM-like activity might function upstream of Chk1 in
Xenopus. A number of ATM homologues have been
identified in human cells and the precise role of each of
these proteins in human checkpoint control is just begin-
ning to emerge [23]. Inhibition of other members of this
structurally and functionally related family of proteins
by caffeine might explain the pleiotropic and potent
effects of caffeine. The high concentrations of caffeine
required to produce radiosensitivity have hampered its
usefulness as a clinical agent. Nevertheless, the observa-
tion that ATM is a cellular target of caffeine provides a
framework from which its properties as an adjunct in
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ATM is inhibited by caffeine in vitro. (a) ATM immunoprecipitates from
ATM+/+ or ATM–/– lymphoblasts, or from HeLa cells, were divided
equally and incubated with 1 µg PHAS-I in the absence (–) or presence
(+) of 0.5 µM wortmannin, or in the presence of 2 mM caffeine. ATM
kinase activity was assayed in vitro using [γ-32P]ATP. The products of
the phosphorylation reaction were analyzed by autoradiography
following SDS–PAGE. S corresponds to 1 µg of PHAS-I incubated
alone; Asn, asynchronous HeLa cells; Rad, irradiated HeLa cells.
Phosphorylation of PHAS-I was reduced to 5 ± 5% in the presence of
0.5 µM wortmannin and to 20 ± 10% in the presence of 2 mM caffeine
compared with the corresponding controls. (b) T293 cells were
transfected with expression vectors encoding Omni-tagged wild-type
(WT) or kinase-inactive ATM. After 48 h, ATM was immunoprecipitated
using an antibody to the tag and assayed for kinase activity in vitro
using PHAS-I as substrate in the presence of the indicated
concentration of caffeine or wortmannin. Immunoblot analysis confirmed
that equivalent amounts of WT and kinase-inactive ATM were recovered
in the immunoprecipitates (right-hand panel). (c) Immunoprecipitates of
ATM from human lymphoblasts (ATM+/+) or HeLa cells phosphorylate
6His–Cds1D/A (0.5 µg) purified from baculovirus-infected Sf9 cells.
Phosphorylation of Cds1 was reduced to 5 ± 2% of control in the
presence of 0.5 µM wortmannin and to 15 ± 5% in the presence of
2 mM caffeine. S corresponds to 0.5 µg 6His–Cds1D/A incubated
alone. (d) Cds1 activity from ATM+/+ and ATM–/– human lymphoblasts
was assayed after irradiation in the presence of caffeine or wortmannin,
as indicated. The residual activation of Cds1 in ATM–/– cells is sensitive
to caffeine and wortmannin. The right-hand panel is a ten-times longer
exposure of the same gel. Results are representative of three
independent experiments. Similar results were obtained with ATM+/+
and ATM–/– human fibroblasts (data not shown).
radiation therapy and chemotherapy can be understood,
and may provide a framework for the rational design of
more specific radiosensitizers.
Materials and methods
Kinase assays
ATM immunoprecipitates were essentially as described in [16]. Cell
lysate (1 mg) was incubated with 1 µg of anti-ATM antibody (H-248;
Santa Cruz Biotechnology) and Protein A Sepharose (Pharmacia). The
precipitated beads were washed three times with lysis buffer as in [16]
and three times with 50 mM Imidazole pH 7.4, 50 mM NaCl, 10 mM
MgCl2, 10 mM MnCl2 and 1 mM DTT. PHAS-I (1 µg; Stratagene) or
6His–Cds1D/A (0.5 µg) was used as substrate. Kinase reactions were
initiated by the addition of 50 µM ATP and 15 µCi [γ-32P]ATP. After
15 min at 30°C, reactions were terminated by the addition of SDS and
analyzed by autoradiography following SDS–PAGE. The 6His–Cds1
purified from Sf9 cells was assayed using a synthetic peptide corre-
sponding to residues 208–225 of Cdc25c. The kinase reaction con-
tained 0.1 mg/ml peptide, 50 mM Imidazole pH 7.4, 10 mM MgCl2,
0.1 mM ATP, 1 µCi [γ-32P]ATP and 0.2 µg 6His–Cds1. Reactions
were incubated at 30°C for 15 min and terminated by adding 5%
trichloroacetic acid. The reaction products were spotted onto
P81(Whatman) paper and phosphorylation of the peptide was mea-
sured by scintillation counting.
Cell lines
Normal human lymphoblasts (GM02184D) and ATM–/– lymphoblasts
(GM03189D) where obtained from Coriell Institute for Medical
Research (Camden, New Jersey).
Supplementary material
Supplementary material including additional data and methodological
detail is available at http://current-biology.com/supmat/supmatin.htm.
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Figure 3
Schematic diagram showing how caffeine overrides DNA-damage
checkpoints by inhibiting ATM. Activation of Cds1 and p53 is blocked
in the presence of caffeine. Cells therefore fail to delay in G1 or G2 in
response to DNA damage. Inhibition of ATM and/or other unidentified
homologues of ATM by caffeine could lead to a loss of checkpoints
induced by replication or ultraviolet (UV) damage that are not
dependent on ATM.
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